or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    TCBP F TC BioPharm (Holdings) plc -15.17
    CLLS B Cellectis S.A. -7.46
    ALRN D Aileron Therapeutics, Inc. -6.58
    IMRX F Immuneering Corporation -5.45
    ONCT D Oncternal Therapeutics, Inc. -5.33
    IMMX F Immix Biopharma, Inc. -5.15
    CASI F CASI Pharmaceuticals, Inc. -5.09
    AFMD D Affimed Therapeutics B.V. -4.74
    RLAY F Relay Therapeutics, Inc. -4.53
    HOWL C Werewolf Therapeutics, Inc. -4.35
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Biopharmaceutical Cancer Advanced Solid Tumors Biology Biotechnology Hematologic Malignancies Life Sciences Lymphoma Medicine Treatment Of Cancer Acute Myeloid Leukemia Autoimmune Disease Blastoma CD19 Cancer Immunotherapy Cancer Treatment Cell Biology Chronic Lymphocytic Leukemia Clinical Development Drug Development

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 1.99
    WDNA D WisdomTree BioRevolution Fund 0.96
    GNOM D Global X Genomics & Biotechnology ETF 0.54
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 0.5
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.41
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CNCR to LABD Compare GNOM to BBC Compare WDNA to GNOM

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 7 ALRN Down -36.29% in 4 Weeks, Here's Why Aileron Therapeutics (ALRN) Looks Ripe for a Turnaround
        May 6 ALRN Aileron Therapeutics to Present at Two Upcoming Investor Conferences
        May 6 TCBP TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
        May 6 HOWL The Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 Experts
        May 6 TCBP TC Biopharm executes second LOI to buy CAR-T therapies, shares up
        May 6 TCBP TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
        May 4 RLAY Relay Therapeutics First Quarter 2024 Earnings: Beats Expectations
        May 3 ALRN Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
        May 3 HOWL Werewolf Therapeutics GAAP EPS of -$0.39, revenue of $0.74M
        May 3 HOWL Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
        May 3 RLAY Relay Therapeutics GAAP EPS of -$0.62 beats by $0.10, revenue of $10.01M beats by $9.09M
        May 2 RLAY Relay Therapeutics Outperforms Revenue Expectations in Q1 2024
        May 2 RLAY Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
        May 2 CLLS Cellectis announces CFO departure
        May 2 CLLS Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
        May 2 RLAY Relay Therapeutics GAAP EPS of -$0.62 beats by $0.08, revenue of $10M beats by $9.89M
        May 2 ONCT Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results
        May 2 RLAY Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
        May 2 ALRN Aileron reports data from Cohort 1 of Phase Ib inhaled IPF treatment trial
        May 1 ALRN Aileron announces pricing of underwritten registered direct offering priced at-the-market under Nasdaq rules of up to about $40M
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Medicine Biopharmaceutical Cancer Clinical Medicine Cancer Treatment Leukemia Lymphoma Ovarian Cancer Biotechnology Advanced Solid Tumors Cancer Immunotherapy Cell Therapy Chimeric Antigen Receptor T Cell Clinical Development Drugs Immune System Immunotherapy Multiple Myeloma Non Small Cell Lung Cancer Oncolytics Biotech
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags